Canaccord Genuity Q2 Preview on Quest Diagnostics (NYSE: DGX): Sidelined Until More Confident in New CEO's Ability

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. SPY
6. MRK
7. HD
8. DVLT
9. MRCY
10. LOW

Go back to Canaccord Genuity Q2 Preview on Quest Diagnostics (NYSE: DGX): Sidelined Until More Confident in New CEO's Ability
Quest Diagnostics (NYSE: DGX) Delayed: 241.76 +5.51 (2.33%)
Previous Close $236.25    52 Week High $86.85 
Open $238.10    52 Week Low $59.66 
Day High $242.39    P/E 45.53 
Day Low $237.38    EPS $5.31 
Volume 924,009